Hepatitis B virus (HBV) infection causes chronic hepatitis and has long term complications.
Individuals ever infected with HBV are at risk of viral reactivation under certain …

Psoriasis is a common inflammatory skin disease with multiple comorbidities, including
psoriatic arthritis and coronary artery disease, that can severely impact an individual's …

The emergence of data from clinical trials of biologics, the approval of new biologics, and
our improved understanding of psoriasis pathogenesis have increased the therapeutic …

HBV reactivation (HBVr) can be prevented by nucleos (t) ide analogues (NAs). We
conducted a systematic review and meta-analysis on the risk of HBVr associated with new …

The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …

Introduction: Despite the therapeutic effectiveness of biologics targeting immune cells or
cytokines in patients with inflammatory arthritis, which reflects their pathogenic roles, an …

In patients with rheumatic diseases undergoing immunosuppressive treatment, hepatitis B
virus reactivation (HBVr) has been long recognized as a major treatment-related adverse …

To date, an estimated 300 million people worldwide have been infected with chronic
hepatitis B virus (HBV). Although anti-HBV therapies have improved the long-term survival …

Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive
medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral …

Hepatitis B virus (HBV) reactivation can be precipitated following the use of
immunosuppressive agents and chemotherapy and can be a serious manifestation. HBV a …